Physician profile
David E Smith
NPI 1356753370
$1,147.06
in general payments reported to CMS, 2019-2025
13 companies · $155 in 2025
The $155 reported for 2025 was more than what 75% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.94 · 2021: $489 · 2022: $52.82 · 2023: $94.08 · 2024: $319 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $489.01 | 2021 | |
| Intuitive Surgical, INC. | $168.37 | 2024 | |
| Myriad Genetic Laboratories, INC. | $115.66 | 2024 | Myrisk |
| Merck Sharp & Dohme LLC | $108.59 | 2022-2025 | Bridion |
| Becton, Dickinson and Company | $52.50 | 2025 | Hemosphere |
| Octapharma USA, INC. | $43.73 | 2025 | Fibryga |
| Boston Scientific Corporation | $36.94 | 2019 | |
| Tactile Systems Technology INC | $33.98 | 2022 | |
| Ethicon US, LLC | $27.80 | 2023 | Megadyne |
| Heron Therapeutics, INC. | $19.62 | 2025 | Aponvie |
| Edwards Lifesciences Corporation | $18.67 | 2024 | Hemosphere |
| Vertex Pharmaceuticals Incorporated | $16.11 | 2025 | |
| B. Braun Medical INC. | $16.08 | 2024 | Perifix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.